On the public citation graph
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
0 signed · 417 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archsurg.138.11.1240openalex-snapshot
Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery
inferredcites →https://doi.org/10.1001/jama.2011.1437openalex-snapshot
Vitamin E and the Risk of Prostate Cancer
inferredcites →https://doi.org/10.1001/jama.297.8.842openalex-snapshot
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
inferredcites →https://doi.org/10.1001/jama.298.10.1180openalex-snapshot
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
inferredcites →https://doi.org/10.1002/14651858.cd007340.pub2openalex-snapshot
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
inferredcites →https://doi.org/10.1002/hep.1840380427openalex-snapshot
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
inferredcites →https://doi.org/10.1002/hep.20092openalex-snapshot
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
inferredcites →https://doi.org/10.1002/hep.20466openalex-snapshot
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
inferredcites →https://doi.org/10.1002/hep.20543openalex-snapshot
Chronological development of elevated aminotransferases in a nonalcoholic population
inferredcites →https://doi.org/10.1002/hep.20701openalex-snapshot
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
inferredcites →https://doi.org/10.1002/hep.21223openalex-snapshot
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.21248openalex-snapshot
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
inferredcites →https://doi.org/10.1002/hep.21327openalex-snapshot
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
inferredcites →https://doi.org/10.1002/hep.21346openalex-snapshot
Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease†
inferredcites →https://doi.org/10.1002/hep.21391openalex-snapshot
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious†‡
inferredcites →https://doi.org/10.1002/hep.21984openalex-snapshot
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
inferredcites →https://doi.org/10.1002/hep.22575openalex-snapshot
Orlistat for overweight subjects with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.22603openalex-snapshot
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23270openalex-snapshot
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
inferredcites →https://doi.org/10.1002/hep.23276openalex-snapshot
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23312openalex-snapshot
Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.23314openalex-snapshot
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
inferredcites →https://doi.org/10.1002/hep.23527openalex-snapshot
the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23727openalex-snapshot
High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.24127openalex-snapshot
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ
inferredcites →https://doi.org/10.1002/hep.24491openalex-snapshot
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
inferredcites →https://doi.org/10.1002/hep.24558openalex-snapshot
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
inferredcites →https://doi.org/10.1002/hep.25539openalex-snapshot
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.25739openalex-snapshot
Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.510290347openalex-snapshot
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
inferredcites →https://doi.org/10.1002/hep.510300604openalex-snapshot
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1007/s00534-009-0187-2openalex-snapshot
Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system
inferredcites →https://doi.org/10.1007/s00535-006-1790-5openalex-snapshot
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1007/s00535-012-0527-xopenalex-snapshot
Inflammation and fibrogenesis in steatohepatitis
inferredcites →https://doi.org/10.1007/s12072-011-9277-8openalex-snapshot
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network
inferredcites →https://doi.org/10.1016/0016-5085(90)91169-7openalex-snapshot
Effect of weight reduction on hepatic abnormalities in overweight patients
inferredcites →https://doi.org/10.1016/0168-8278(91)90942-5openalex-snapshot
Hepatic effects of dietary weight loss in morbidly obese subjects
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2008.12.019openalex-snapshot
Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?
inferredcites →https://doi.org/10.1016/j.cgh.2008.08.012openalex-snapshot
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1016/j.cgh.2008.11.005openalex-snapshot
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
inferredcites →https://doi.org/10.1016/j.clinbiochem.2010.04.003openalex-snapshot
Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes
inferredcites →https://doi.org/10.1016/j.clinbiochem.2012.03.024openalex-snapshot
Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation
inferredcites →https://doi.org/10.1016/j.dld.2006.03.021openalex-snapshot
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
inferredcites →https://doi.org/10.1016/j.dld.2007.10.003openalex-snapshot
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.ejrad.2006.11.005openalex-snapshot
Imaging of hepatic steatosis and fatty sparing
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2011.10.003openalex-snapshot
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2004.09.012openalex-snapshot
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
inferredcites →https://doi.org/10.1016/j.jhep.2007.02.007openalex-snapshot
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
inferredcites →https://doi.org/10.1016/j.jhep.2007.06.020openalex-snapshot
Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study
inferredcites →https://doi.org/10.1016/j.jhep.2009.03.019openalex-snapshot
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2010.04.030openalex-snapshot
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
inferredcites →https://doi.org/10.1016/j.jhep.2010.08.030openalex-snapshot
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2011.03.020openalex-snapshot
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
inferredcites →https://doi.org/10.1016/s0002-9270(99)00433-5openalex-snapshot
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
inferredcites →https://doi.org/10.1016/s0009-9260(05)80350-2openalex-snapshot
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
inferredcites →https://doi.org/10.1016/s0016-5085(98)70599-2openalex-snapshot
Steatohepatitis: A tale of two “hits”?
inferredcites →https://doi.org/10.1016/s0025-6196(24)00530-5openalex-snapshot
Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/s0140-6736(10)61272-xopenalex-snapshot
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
inferredcites →https://doi.org/10.1016/s0168-8278(97)80287-5openalex-snapshot
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
inferredcites →https://doi.org/10.1016/s0739-5930(09)79298-0openalex-snapshot
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/s1542-3565(04)00440-9openalex-snapshot
Nonalcoholic fatty liver disease: A review of current understanding and future impact
inferredcites →https://doi.org/10.1016/s1665-2681(19)31616-3openalex-snapshot
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens
inferredcites →https://doi.org/10.1016/s1665-2681(19)31922-2openalex-snapshot
Prevalence of non-alcoholic fatty liver disease: population based study
inferredcites →https://doi.org/10.1023/a:1005661516165openalex-snapshot
Fatty Infiltration of Liver in Hyperlipidemic Patients
inferredcites →https://doi.org/10.1038/ajg.2010.299openalex-snapshot
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
inferredcites →https://doi.org/10.1038/ajg.2011.327openalex-snapshot
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1038/ejcn.2010.139openalex-snapshot
Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women
inferredcites →https://doi.org/10.1038/hr.2010.45openalex-snapshot
Fatty liver incidence and predictive variables
inferredcites →https://doi.org/10.1038/nrgastro.2009.33openalex-snapshot
Endocrine and liver interaction: the role of endocrine pathways in NASH
inferredcites →https://doi.org/10.1053/j.gastro.2004.02.015openalex-snapshot
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
inferredcites →https://doi.org/10.1053/j.gastro.2004.08.052openalex-snapshot
Serum markers detect the presence of liver fibrosis: A cohort study
inferredcites →https://doi.org/10.1053/j.gastro.2005.03.084openalex-snapshot
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2005.04.014openalex-snapshot
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
inferredcites →https://doi.org/10.1053/j.gastro.2008.03.078openalex-snapshot
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
inferredcites →https://doi.org/10.1053/j.gastro.2008.06.047openalex-snapshot
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2009.04.052openalex-snapshot
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
inferredcites →https://doi.org/10.1053/j.gastro.2009.09.072openalex-snapshot
Evaluation of a Focal Lesion in the Liver
inferredcites →https://doi.org/10.1053/j.gastro.2011.06.061openalex-snapshot
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
inferredcites →https://doi.org/10.1053/j.gastro.2012.02.003openalex-snapshot
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
inferredcites →https://doi.org/10.1055/s-0028-1091980openalex-snapshot
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1055/s-0030-1267539openalex-snapshot
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1055/s-0031-1276643openalex-snapshot
Genetics of Alcoholic and Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1055/s-0032-1306423openalex-snapshot
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1056/nejmoa060326openalex-snapshot
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1056/nejmoa072761openalex-snapshot
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
inferredcites →https://doi.org/10.1056/nejmoa0907929openalex-snapshot
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1067/j.cpradiol.2009.05.001openalex-snapshot
Gamut of Focal Fatty Lesions in the Liver: Imaging Manifestations with Emphasis on Magnetic Resonance Imaging
inferredcites →https://doi.org/10.1089/met.2010.0140openalex-snapshot
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes
inferredcites →https://doi.org/10.1093/ajcp/63.3.318openalex-snapshot
Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease
inferredcites →https://doi.org/10.1097/00000441-200502000-00002openalex-snapshot
Patients with Elevated Baseline Liver Enzymes Do Not Have Higher Frequency of Hepatotoxicity from Lovastatin than Those with Normal Baseline Liver Enzymes
inferredcites →https://doi.org/10.1097/00004836-200608000-00015openalex-snapshot
Nonalcoholic Fatty Liver Disease Presenting With an Isolated Elevated Alkaline Phosphatase
inferredcites →https://doi.org/10.1097/00007890-200006150-00034openalex-snapshot
Selection and Outcome of Living Donors for Adult to Adult Right Lobe Transplantation
inferredcites →https://doi.org/10.1097/01.crd.0000380842.14048.7eopenalex-snapshot
Diagnosis and Management of the Metabolic Syndrome
inferredcites →https://doi.org/10.1097/01.mcg.0000225583.32588.5eopenalex-snapshot
Nonalcoholic Fatty Liver Disease Induced by Leuprorelin Acetate
inferredcites →https://doi.org/10.1097/mcg.0b013e31815591aaopenalex-snapshot
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1097/meg.0b013e32832e2bafopenalex-snapshot
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1097/mpg.0b013e31820e82a1openalex-snapshot
A 3‐year‐old With Immunoglobulin G4‐associated Cholangitis
inferredcites →https://doi.org/10.1097/mpg.0b013e31822578dbopenalex-snapshot
Mechanisms of Lipotoxicity in NAFLD and Clinical Implications
inferredcites →https://doi.org/10.1097/pap.0b013e318220f59bopenalex-snapshot
Update on Fatty Liver Disease and Steatohepatitis
inferredcites →https://doi.org/10.1111/j.1365-2036.2006.02885.xopenalex-snapshot
Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study
inferredcites →https://doi.org/10.1111/j.1365-2036.2011.04724.xopenalex-snapshot
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
inferredcites →https://doi.org/10.1111/j.1365-2036.2011.04912.xopenalex-snapshot
Meta‐analysis: pioglitazone improves liver histology and fibrosis in patients with non‐alcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/j.1440-1746.2008.05740.xopenalex-snapshot
An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome
inferredcites →https://doi.org/10.1111/j.1440-1746.2010.06614.xopenalex-snapshot
Hepatobiliary and Pancreatic: Focal steatohepatitis mimicking a metastasis
inferredcites →https://doi.org/10.1111/j.1440-1746.2011.07018.xopenalex-snapshot
Pathophysiology guided treatment of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/j.1440-1746.2012.07084.xopenalex-snapshot
Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis?
inferredcites →https://doi.org/10.1111/j.1572-0241.2005.41583.xopenalex-snapshot
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1126/science.1204265openalex-snapshot
Human Fatty Liver Disease: Old Questions and New Insights
inferredcites →https://doi.org/10.1136/gut.2003.019984openalex-snapshot
Long term prognosis of fatty liver: risk of chronic liver disease and death
inferredcites →https://doi.org/10.1136/gut.2009.205088openalex-snapshot
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
inferredcites →https://doi.org/10.1136/gut.2010.218214openalex-snapshot
Non-alcoholic fatty liver disease: what's new under the microscope?
inferredcites →https://doi.org/10.1148/radiographics.18.6.9821195openalex-snapshot
Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance.
inferredcites →https://doi.org/10.1148/radiol.2393042218openalex-snapshot
Hepatic Macrosteatosis: Predicting Appropriateness of Liver Donation by Using MR Imaging—Correlation with Histopathologic Findings
inferredcites →https://doi.org/10.1148/rg.266065004openalex-snapshot
Fatty Liver: Imaging Patterns and Pitfalls
inferredcites →https://doi.org/10.1152/ajpendo.00064.2004openalex-snapshot
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
inferredcites →https://doi.org/10.1161/circulationaha.105.169404openalex-snapshot
Diagnosis and Management of the Metabolic Syndrome
inferredcites →https://doi.org/10.1177/1740774508101279openalex-snapshot
Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality
inferredcites →https://doi.org/10.1177/1756283x09105462openalex-snapshot
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
inferredcites →https://doi.org/10.1179/acb.2009.084openalex-snapshot
IDENTIFYING NON-ALCOHOLIC FATTY LIVER DISEASE AMONG ASYMPTOMATIC OVERWEIGHT AND OBESE INDIVIDUALS BY CLINICAL AND BIOCHEMICAL CHARACTERISTICS
inferredcites →https://doi.org/10.1186/1423-0127-19-26openalex-snapshot
Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress
inferredcites →https://doi.org/10.1210/en.2010-0537openalex-snapshot
GH-Dependent STAT5 Signaling Plays an Important Role in Hepatic Lipid Metabolism
inferredcites →https://doi.org/10.1210/jc.84.5.1513openalex-snapshot
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
inferredcites →https://doi.org/10.1259/0007-1285-52-615-184openalex-snapshot
Ultrasound in the detection of chronic liver disease (the “bright liver”)
inferredcites →https://doi.org/10.1371/journal.pone.0022775openalex-snapshot
Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
inferredcites →https://doi.org/10.1381/0960892055002347openalex-snapshot
Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass
inferredcites →https://doi.org/10.1586/egh.11.4openalex-snapshot
Autophagy in nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1586/egh.11.6openalex-snapshot
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
inferredcites →https://doi.org/10.1631/jzus.b0720016openalex-snapshot
Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1900/rds.2011.8.454openalex-snapshot
Hepatic Steatosis in Type 1 Diabetes
inferredcites →https://doi.org/10.2174/1874609811104020158openalex-snapshot
Vitamin E and All-Cause Mortality: A Meta-Analysis
inferredcites →https://doi.org/10.2214/ajr.11.6729openalex-snapshot
MRI Steatosis Grading: Development and Initial Validation of a Color Mapping System
inferredcites →https://doi.org/10.2214/ajr.171.3.9725292openalex-snapshot
Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT.
inferredcites →https://doi.org/10.2337/db08-1074openalex-snapshot
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
inferredcites →https://doi.org/10.2337/dc10-1991openalex-snapshot
Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes
inferredcites →https://doi.org/10.2337/diabetes.54.11.3140openalex-snapshot
Liver Markers and Development of the Metabolic Syndrome
inferredcites →https://doi.org/10.3109/07853890.2010.518623openalex-snapshot
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
inferredcites →https://doi.org/10.3109/09637486.2010.487480openalex-snapshot
Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study
inferredcites →https://doi.org/10.3346/jkms.1995.10.6.414openalex-snapshot
Effect of weight control on hepatic abnormalities in obese patients with fatty liver
inferredcites →https://doi.org/10.3748/wjg.14.487openalex-snapshot
Natural killer T cells and non-alcoholic fatty liver disease: Fat chews on the immune system
inferredcites →https://doi.org/10.3748/wjg.v16.i37.4652openalex-snapshot
Roles of liver innate immune cells in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.3748/wjg.v18.i8.727openalex-snapshot
Role of cytokines and chemokines in non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.7326/0003-4819-142-1-200501040-00110openalex-snapshot
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
inferredcites →https://doi.org/10.7326/0003-4819-143-10-200511150-00009openalex-snapshot
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.7861/clinmedicine.7-2-119openalex-snapshot
Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4841348openalex-extracted
Zuogui-Jiangtang-Qinggan Formula Alleviated Hepatic Steatosis in Diabetes by Improving Energy and Bile Acid Metabolism: Based on Multi-Omics Integration Studies
inferred← citesno DOI in the source recordopenalex-snapshot
Staphylococcal nasal carriage of health care workers.
inferred← citeshttps://doi.org/10.1002/9781118924938.ch6openalex-snapshot
Is NAFLD different in absence of metabolic syndrome?
inferred← citeshttps://doi.org/10.1002/cpdd.762openalex-snapshot
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers
inferred← citeshttps://doi.org/10.1002/fsn3.3315openalex-snapshot
Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta‐analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1002/hep.28820openalex-snapshot
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice
inferred← citeshttps://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferred← citeshttps://doi.org/10.1002/jcp.29870openalex-snapshot
Expression of NF‐κB, IL‐6, and IL‐10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD—Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple‐blind randomized controlled clinical trial
inferred← citeshttps://doi.org/10.1002/jcph.768openalex-snapshot
Effect of Disease Pathologies on Transporter Expression and Function
inferred← citeshttps://doi.org/10.1002/lipd.12219openalex-snapshot
Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model
inferred← citeshttps://doi.org/10.1002/path.5131openalex-snapshot
Geranylgeranyl diphosphate synthase (GGPPS) regulates non‐alcoholic fatty liver disease (NAFLD)–fibrosis progression by determining hepatic glucose/fatty acid preference under high‐fat diet conditions
inferred← citeshttps://doi.org/10.1002/prca.201700028openalex-snapshot
Alteration of Liver Peroxisomal and Mitochondrial Functionality in the NZO Mouse Model of Metabolic Syndrome
inferred← citeshttps://doi.org/10.1002/prp2.820openalex-snapshot
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single‐center observational study
inferred← citeshttps://doi.org/10.1007/978-1-4939-9488-5_20openalex-snapshot
Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-15052-4_9openalex-snapshot
Psychiatric Aspects of Obesity in Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-29149-9_12openalex-snapshot
Treatment of Hepatic Malignances and Disorders: The Role of Liver Bioengineering
inferred← citeshttps://doi.org/10.1007/978-981-19-5642-3_13openalex-snapshot
Genome Editing and Fatty Liver
inferred← citeshttps://doi.org/10.1007/s00335-016-9658-3openalex-snapshot
Mapping liver fat female-dependent quantitative trait loci in collaborative cross mice
inferred← citeshttps://doi.org/10.1007/s00775-020-01821-zopenalex-snapshot
Selenoprotein F knockout leads to glucose and lipid metabolism disorders in mice
inferred← citeshttps://doi.org/10.1007/s10620-016-4124-3openalex-snapshot
Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation
inferred← citeshttps://doi.org/10.1007/s10620-016-4213-3openalex-snapshot
Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10620-019-05516-7openalex-snapshot
Immunotherapy: Current Status and Future Perspectives
inferred← citeshttps://doi.org/10.1007/s11154-013-9274-4openalex-snapshot
Adipose tissue inflammation in glucose metabolism
inferred← citeshttps://doi.org/10.1007/s11377-013-0823-xopenalex-snapshot
Die nichtalkoholische Steatohepatitis als viszerale Manifestation des metabolischen Syndroms
inferred← citeshttps://doi.org/10.1007/s11695-016-2123-2openalex-snapshot
Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency
inferred← citeshttps://doi.org/10.1007/s11695-020-04509-0openalex-snapshot
Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds
inferred← citeshttps://doi.org/10.1007/s12022-013-9288-1openalex-snapshot
Morphological and Inflammatory Changes in Visceral Adipose Tissue During Obesity
inferred← citeshttps://doi.org/10.1007/s12291-016-0612-7openalex-snapshot
Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation
inferred← citeshttps://doi.org/10.1007/s12325-020-01493-wopenalex-snapshot
A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s12664-020-01021-2openalex-snapshot
Treatment of non-alcoholic fatty liver disease — Current perspectives
inferred← citeshttps://doi.org/10.1016/b978-0-12-374279-7.19008-3openalex-snapshot
The Immunology of Adipose Tissue
inferred← citeshttps://doi.org/10.1016/b978-0-12-410396-2.00034-7openalex-snapshot
Translational Regenerative Medicine—Hepatic Systems
inferred← citeshttps://doi.org/10.1016/b978-0-12-824465-4.00167-8openalex-snapshot
Physiology of the Immune System: Immunology of Adipose Tissue
inferred← citeshttps://doi.org/10.1016/b978-0-443-32848-0.00023-6openalex-snapshot
Emerging therapeutic approaches in neurobiology of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.abb.2014.05.013openalex-snapshot
Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2018.07.028openalex-snapshot
Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis
inferred← citeshttps://doi.org/10.1016/j.amjms.2024.01.022openalex-snapshot
ALT poorly predicts Nonalcoholic Fatty Liver Disease (NAFLD) and liver fibrosis as determined by vibration-controlled transient elastography in adult National Health and Nutrition Examination Survey 2017–2018
inferred← citeshttps://doi.org/10.1016/j.arcmed.2018.04.013openalex-snapshot
ACE, APOA5, and MTP Gene Polymorphisms Analysis in Relation to Triglyceride and Insulin Levels in Pediatric Patients
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2014.01.053openalex-snapshot
Visceral/epicardial adiposity in nonobese and apparently healthy young adults: Association with the cardiometabolic profile
inferred← citeshttps://doi.org/10.1016/j.bbalip.2022.159218openalex-snapshot
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling
inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.05.187openalex-snapshot
Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.06.018openalex-snapshot
Cyanidin-3-O-β-glucoside regulates the activation and the secretion of adipokines from brown adipose tissue and alleviates diet induced fatty liver
inferred← citeshttps://doi.org/10.1016/j.celrep.2023.112627openalex-snapshot
Inhibition of high-fat diet-induced inflammatory responses in adipose tissue by SF1-expressing neurons of the ventromedial hypothalamus
inferred← citeshttps://doi.org/10.1016/j.cgh.2019.04.034openalex-snapshot
Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups
inferred← citeshttps://doi.org/10.1016/j.clnesp.2020.10.020openalex-snapshot
The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study
inferred← citeshttps://doi.org/10.1016/j.cmet.2016.12.022openalex-snapshot
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.106789openalex-snapshot
Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLD
inferred← citeshttps://doi.org/10.1016/j.cyto.2016.01.023openalex-snapshot
Role of antigen presentation in the production of pro-inflammatory cytokines in obese adipose tissue
inferred← citeshttps://doi.org/10.1016/j.diabet.2023.101432openalex-snapshot
Concise review of lipidomics in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.endien.2022.02.017openalex-snapshot
Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity
inferred← citeshttps://doi.org/10.1016/j.endinu.2021.04.007openalex-snapshot
Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity
inferred← citeshttps://doi.org/10.1016/j.engmed.2025.100070openalex-snapshot
Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.fbio.2025.106733openalex-snapshot
Mulberry polyphenols alleviate nonalcoholic fatty liver disease: Action mechanisms via modulating the gut microbiota and PI3K-Akt signaling pathway
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2014.03.005openalex-snapshot
Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e35498openalex-snapshot
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds
inferred← citeshttps://doi.org/10.1016/j.ijsu.2020.01.139openalex-snapshot
Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research
inferred← citeshttps://doi.org/10.1016/j.jacc.2018.11.050openalex-snapshot
Nonalcoholic Fatty Liver Disease and the Heart
inferred← citeshttps://doi.org/10.1016/j.jep.2017.06.030openalex-snapshot
Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation
inferred← citeshttps://doi.org/10.1016/j.jgr.2018.10.005openalex-snapshot
Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.12.012openalex-snapshot
NAFLD: A multisystem disease
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2015.07.002openalex-snapshot
Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2015.12.015openalex-snapshot
Urinary metabolic profile predicts high-fat diet sensitivity in the C57Bl6/J mouse
inferred← citeshttps://doi.org/10.1016/j.knosys.2014.11.021openalex-snapshot
Ultrasound-based tissue characterization and classification of fatty liver disease: A screening and diagnostic paradigm
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118986openalex-snapshot
Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120732openalex-snapshot
The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
inferred← citeshttps://doi.org/10.1016/j.mcna.2018.08.005openalex-snapshot
The Future of Nonalcoholic Fatty Liver Disease Treatment
inferred← citeshttps://doi.org/10.1016/j.mehy.2016.08.013openalex-snapshot
Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?
inferred← citeshttps://doi.org/10.1016/j.mgene.2016.08.009openalex-snapshot
Gene polymorphisms of desaturase enzymes of polyunsaturated fatty acid metabolism and adiponutrin and the increased risk of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104770openalex-snapshot
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes
inferred← citeshttps://doi.org/10.1016/j.tjnut.2024.03.007openalex-snapshot
Hepatic Effects of Low-Carbohydrate Diet Associated with Different Lipid Sources: Insights into Oxidative Stress, Cytotoxicity, and Epigenetic Markers in a mouse Model of Obesity
inferred← citeshttps://doi.org/10.1016/j.tjnut.2024.10.041openalex-snapshot
Possible Metabolic Remodeling based on de novo Biosynthesis of L-serine in Se-Subtoxic or -Deficient Mammals
inferred← citeshttps://doi.org/10.1016/j.toxlet.2024.08.009openalex-snapshot
Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK
inferred← citeshttps://doi.org/10.1016/j.transproceed.2013.12.055openalex-snapshot
Extreme Heatstroke Causing Fulminant Hepatic Failure Requiring Liver Transplantation: A Case Report
inferred← citeshttps://doi.org/10.1017/s0954422417000269openalex-snapshot
Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.5c00157openalex-snapshot
Flavonoid–Sesquiterpenoid Hybrids from the Leaves of Syzygium simile and Their Anti-Lipid Droplet Accumulation Activities
inferred← citeshttps://doi.org/10.1038/ajg.2014.132openalex-snapshot
Mortality From Chronic Liver Diseases in Diabetes
inferred← citeshttps://doi.org/10.1038/s41598-020-71210-8openalex-snapshot
Exploring the genetic basis of fatty liver development in geese
inferred← citeshttps://doi.org/10.1038/s41598-021-85051-6openalex-snapshot
Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice
inferred← citeshttps://doi.org/10.1038/s41598-023-28647-4openalex-snapshot
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
inferred← citeshttps://doi.org/10.1038/srep46458openalex-snapshot
Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population
inferred← citeshttps://doi.org/10.1039/c6ra26046bopenalex-snapshot
Catalpol prevents alteration of cholesterol homeostasis in non-alcoholic fatty liver disease via attenuating endoplasmic reticulum stress and NOX4 over-expression
inferred← citeshttps://doi.org/10.1039/d4fo01461hopenalex-snapshot
A systematic review and meta-analysis of randomized controlled trials: effects of mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD
inferred← citeshttps://doi.org/10.1053/j.gastro.2015.04.009openalex-snapshot
Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice
inferred← citeshttps://doi.org/10.1053/j.sempedsurg.2013.10.016openalex-snapshot
Nonalcoholic fatty liver disease and bariatric surgery in adolescents
inferred← citeshttps://doi.org/10.1055/s-0046-1819600openalex-snapshot
Exploring the Relationship Between Hypothyroidism and Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1074/jbc.m115.692244openalex-snapshot
Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells
inferred← citeshttps://doi.org/10.1074/jbc.m117.799304openalex-snapshot
Function of inhibitor of Bruton's tyrosine kinase isoform α (IBTKα) in nonalcoholic steatohepatitis links autophagy and the unfolded protein response
inferred← citeshttps://doi.org/10.1074/jbc.rev119.008897openalex-snapshot
The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1080/07391102.2024.2438358openalex-snapshot
Computational dissection through network pharmacology and structure-based analysis unravels mechanistic actions of bioactive compounds in a hepatoprotective herb, Picrorhiza kurroa for the treatment of NAFLD and NASH
inferred← citeshttps://doi.org/10.1080/15287394.2025.2473558openalex-snapshot
Acteoside inhibits hepatic lipid accumulation and oxidative stress in type 2 diabetic mice via the Nrf2/HO-1 Pathway
inferred← citeshttps://doi.org/10.1080/21623945.2015.1038443openalex-snapshot
Chronic treatment with a carbon monoxide releasing molecule reverses dietary induced obesity in mice
inferred← citeshttps://doi.org/10.1089/jmf.2015.0123openalex-snapshot
Lycopene Improves Diet-Mediated Recuperation in Rat Model of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1089/jmf.2018.4226openalex-snapshot
Perilla Oil Decreases Aortic and Hepatic Lipid Accumulation by Modulating Lipogenesis and Lipolysis in High-Fat Diet-Fed Mice
inferred← citeshttps://doi.org/10.1091/mbc.e15-01-0036openalex-snapshot
CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1093/abbs/gmy131openalex-snapshot
Chronic intermittent hypoxia promotes the development of experimental non-alcoholic steatohepatitis by modulating Treg/Th17 differentiation
inferred← citeshttps://doi.org/10.1093/abbs/gmy169openalex-snapshot
Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress
inferred← citeshttps://doi.org/10.1093/jb/mvaa062openalex-snapshot
Arachidonate 12S-lipoxygenase of platelet-type in hepatic stellate cells of methionine and choline-deficient diet-fed mice
inferred← citeshttps://doi.org/10.1093/med/9780198816805.003.0074openalex-snapshot
Viral alcoholic and fatty liver diseases
inferred← citeshttps://doi.org/10.1096/fj.202001234ropenalex-snapshot
Rspo1/Rspo3‐LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPKα‐SREBP2 pathway
inferred← citeshttps://doi.org/10.1097/md.0000000000002621openalex-snapshot
Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women
inferred← citeshttps://doi.org/10.1097/meg.0000000000001519openalex-snapshot
Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1101/577007openalex-snapshot
Hepatoprotective effects of Erythrina abyssinica Lam Ex Dc against Non Alcoholic Fatty Liver Disease in Sprague Dawley Rats
inferred← citeshttps://doi.org/10.1109/icmsci67830.2026.11469554openalex-snapshot
A Convolutional Neural Network (CNN) Analysis of Liver Histology Images to Predict Response to GLP-1 Agonists in NASH
inferred← citeshttps://doi.org/10.1109/memea.2019.8802230openalex-snapshot
FT–IR Saliva Profiling in Patients with Obesity and Obesity–Related Insulin Resistance
inferred← citeshttps://doi.org/10.1111/apt.15314openalex-snapshot
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
inferred← citeshttps://doi.org/10.1111/brv.12178openalex-snapshot
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
inferred← citeshttps://doi.org/10.1111/ced.12672openalex-snapshot
Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/cen.12430openalex-snapshot
Comments on ‘Low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients’
inferred← citeshttps://doi.org/10.1111/hepr.12788openalex-snapshot
Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin‐dependent kinase kinase–AMP‐activated protein kinase–mechanistic target of rapamycin–p70 ribosomal S6 kinase signaling pathway
inferred← citeshttps://doi.org/10.1111/ijcp.14852openalex-snapshot
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
inferred← citeshttps://doi.org/10.1111/jgh.12422openalex-snapshot
Coffee and non‐alcoholic fatty liver disease: Brewing evidence for hepatoprotection?
inferred← citeshttps://doi.org/10.1111/jgh.12428openalex-snapshot
Prevalence of nonalcoholic fatty liver disease in mainland of C hina: A meta‐analysis of published studies
inferred← citeshttps://doi.org/10.1111/jgh.13391openalex-snapshot
Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/jgh.14643openalex-snapshot
Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non‐alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1111/joim.13793openalex-snapshot
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials
inferred← citeshttps://doi.org/10.1111/liv.12813openalex-snapshot
Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones
inferred← citeshttps://doi.org/10.1111/liv.12851openalex-snapshot
Non‐alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in X i'an, C hina: a five‐year cohort study
inferred← citeshttps://doi.org/10.1111/liv.12909openalex-snapshot
I148 M variant in PNPLA 3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/liv.13137openalex-snapshot
Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis
inferred← citeshttps://doi.org/10.1111/nyas.13174openalex-snapshot
Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice
inferred← citeshttps://doi.org/10.1111/obr.12308openalex-snapshot
Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization
inferred← citeshttps://doi.org/10.1111/obr.12370openalex-snapshot
Gut microbiota‐derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity
inferred← citeshttps://doi.org/10.1111/tan.13275openalex-snapshot
Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy
inferred← citeshttps://doi.org/10.1124/dmd.113.055996openalex-snapshot
Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models
inferred← citeshttps://doi.org/10.1136/bmjgast-2016-000114openalex-snapshot
Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
inferred← citeshttps://doi.org/10.1139/apnm-2016-0122openalex-snapshot
“Weighing” the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight?
inferred← citeshttps://doi.org/10.1152/ajpendo.00314.2018openalex-snapshot
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
inferred← citeshttps://doi.org/10.1152/ajpendo.00396.2016openalex-snapshot
Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα
inferred← citeshttps://doi.org/10.1152/ajpendo.00614.2020openalex-snapshot
Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis
inferred← citeshttps://doi.org/10.1152/ajpgi.00196.2015openalex-snapshot
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression
inferred← citeshttps://doi.org/10.1155/2014/472638openalex-snapshot
Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet
inferred← citeshttps://doi.org/10.1155/2014/750860openalex-snapshot
Early Effects of a Hypocaloric, Mediterranean Diet on Laboratory Parameters in Obese Individuals
inferred← citeshttps://doi.org/10.1155/2015/565760openalex-snapshot
Eosinophils Reduce Chronic Inflammation in Adipose Tissue by Secreting Th2 Cytokines and Promoting M2 Macrophages Polarization
inferred← citeshttps://doi.org/10.1155/2015/651734openalex-snapshot
Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo
inferred← citeshttps://doi.org/10.1155/2015/980345openalex-snapshot
Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1155/2016/2384561openalex-snapshot
Perilla Oil Supplementation Ameliorates High-Fat/High-Cholesterol Diet Induced Nonalcoholic Fatty Liver Disease in Rats via Enhanced Fecal Cholesterol and Bile Acid Excretion
inferred← citeshttps://doi.org/10.1155/2016/9071097openalex-snapshot
Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis
inferred← citeshttps://doi.org/10.1155/2017/4740124openalex-snapshot
PNPLA3rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism
inferred← citeshttps://doi.org/10.1155/2018/4956079openalex-snapshot
Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1155/jfbc/3260026openalex-snapshot
Antilipogenic Effect of Cirsium japonicum var. maackii According to Harvest Time and Plant Part in High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1159/000437048openalex-snapshot
Glycogenic Hepatopathy: Thinking Outside the Box
inferred← citeshttps://doi.org/10.1159/000446744openalex-snapshot
Optimizing postoperative outcomes after gastric bypass surgery-the influence of dietary protein and its amino acid composition: A systematic review
inferred← citeshttps://doi.org/10.11603/24116-4944.2022.2.13482openalex-snapshot
КЛІНІЧНИЙ ПЕРЕБІГ ПОЛОГІВ У ЖІНОК З НЕАЛКОГОЛЬНИМ СТЕАТОГЕПАТИТОМ НА ТЛІ ОЖИРІННЯ РІЗНОГО СТУПЕНЯ
inferred← citeshttps://doi.org/10.1172/jci76388openalex-snapshot
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
inferred← citeshttps://doi.org/10.1177/003335491513000619openalex-snapshot
Chronic Liver Disease-Associated Hospitalizations among Adults with Diabetes, National Inpatient Sample, 2001–2012
inferred← citeshttps://doi.org/10.1177/03000605261417053openalex-snapshot
The association between non–high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in non-obese individuals: A cross-sectional study
inferred← citeshttps://doi.org/10.1177/2050640618774140openalex-snapshot
Dietary supplementation of vitamin D prevents the development of western diet‐induced metabolic, hepatic and cardiovascular abnormalities in rats
inferred← citeshttps://doi.org/10.1177/20587384211031417openalex-snapshot
Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2
inferred← citeshttps://doi.org/10.1186/s12876-022-02246-5openalex-snapshot
Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12876-024-03256-1openalex-snapshot
Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES
inferred← citeshttps://doi.org/10.1186/s12906-019-2782-3openalex-snapshot
Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
inferred← citeshttps://doi.org/10.1186/s12916-019-1364-zopenalex-snapshot
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network
inferred← citeshttps://doi.org/10.1186/s12986-023-00775-8openalex-snapshot
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1186/s13063-020-04362-7openalex-snapshot
Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
inferred← citeshttps://doi.org/10.1186/s13578-020-00507-yopenalex-snapshot
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1186/s40360-018-0200-yopenalex-snapshot
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1186/s43044-021-00222-0openalex-snapshot
The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography
inferred← citeshttps://doi.org/10.1210/jc.2016-3440openalex-snapshot
Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly
inferred← citeshttps://doi.org/10.1210/jc.2018-02213openalex-snapshot
Postglucose Hyperinsulinemia in Black Women Is Not What We Thought
inferred← citeshttps://doi.org/10.1210/jc.2019-00021openalex-snapshot
Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.12677/acm.2024.1451434openalex-snapshot
Study on Association between SOCS1 rs243330 Polymorphisms and Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1293/tox.2022-0066openalex-snapshot
Application of convolutional neural network for analyzing hepatic fibrosis in mice
inferred← citeshttps://doi.org/10.13048/jkm.15035openalex-snapshot
Kaurenoic acid, a Diterpene Derived from , Alleviates Lipogenesis in HepG2 Cells.
inferred← citeshttps://doi.org/10.13048/jkm.20044openalex-snapshot
Kaurenoic acid, a natural substance from traditional herbal medicine, alleviates palmitate induced hepatic lipid accumulation via Nrf2 activation
inferred← citeshttps://doi.org/10.1360/ssv-2024-0107openalex-snapshot
Role of selenium and selenoprotein in animal liver health
inferred← citeshttps://doi.org/10.1371/journal.pone.0079270openalex-snapshot
The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
inferred← citeshttps://doi.org/10.1371/journal.pone.0083693openalex-snapshot
Inflammatory Cytokine Gene Expression in Mesenteric Adipose Tissue during Acute Experimental Colitis
inferred← citeshttps://doi.org/10.1371/journal.pone.0100627openalex-snapshot
L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
inferred← citeshttps://doi.org/10.1371/journal.pone.0118650openalex-snapshot
Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?
inferred← citeshttps://doi.org/10.1371/journal.pone.0141227openalex-snapshot
Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet
inferred← citeshttps://doi.org/10.1371/journal.pone.0189965openalex-snapshot
Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
inferred← citeshttps://doi.org/10.1371/journal.pone.0277053openalex-snapshot
Human CYP2B6 produces oxylipins from polyunsaturated fatty acids and reduces diet-induced obesity
inferred← citeshttps://doi.org/10.14218/jcth.2020.00151openalex-snapshot
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.14739/2310-1210.2022.3.252654openalex-snapshot
Nonalcoholic steatohepatitis and obesity: influence of key risk factors on the development of obstetric and perinatal complications in pregnant women
inferred← citeshttps://doi.org/10.1517/17425255.2014.936378openalex-snapshot
Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.15252/embj.2020104705openalex-snapshot
Molecular mechanisms and physiological functions of mitophagy
inferred← citeshttps://doi.org/10.1530/eje-13-0296openalex-snapshot
Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders
inferred← citeshttps://doi.org/10.15406/ghoa.2019.10.00367openalex-snapshot
Diagnostic capabilities and treatment strategies depending on the form of non-alcoholic fatty liver disease in patients with hypertonic disease
inferred← citeshttps://doi.org/10.1638/2015-0173.1openalex-snapshot
LIVER ULTRASONOGRAPHY IN DOLPHINS: USE OF ULTRASONOGRAPHY TO ESTABLISH A TECHNIQUE FOR HEPATOBILIARY IMAGING AND TO EVALUATE METABOLIC DISEASE-ASSOCIATED LIVER CHANGES IN BOTTLENOSE DOLPHINS (TURSIOPS TRUNCATUS)
inferred← citeshttps://doi.org/10.17219/acem/106173openalex-snapshot
Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study
inferred← citeshttps://doi.org/10.18174/387386openalex-snapshot
Diet-induced phenotypic plasticity during aging
inferred← citeshttps://doi.org/10.18297/etd/1272openalex-snapshot
Olanzapine-induced liver injury : direct metabolic effects, exacerbation by high-fat diet, and protection with sulforaphane.
inferred← citeshttps://doi.org/10.20517/mtod.2025.73openalex-snapshot
Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.21037/cco-20-117openalex-snapshot
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
inferred← citeshttps://doi.org/10.21037/qims-21-700openalex-snapshot
Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores
inferred← citeshttps://doi.org/10.21037/tgh.2019.09.08openalex-snapshot
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
inferred← citeshttps://doi.org/10.21123/bsj.2019.16.4(suppl.).0966openalex-snapshot
E4An Ultrastructural Study by Transmission Electron Microscope of Exocrine Pancreatic Cells in Diabetic Rats Treated with Herbal Combination
inferred← citeshttps://doi.org/10.21203/rs.3.rs-113257/v1openalex-snapshot
Evaluation and Diagnosis of Nonalcoholic Fatty Liver Disease/Steatohepatitis by K-Fold Validation Based on Pathology, Including Real-Time Shear Wave Elastography and Noninvasive Biomarkers
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3966322/v1openalex-snapshot
Association between periodontitis and NAFLD-related diseases: Results from the NHANES and Mendelian randomization study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-71535/v1openalex-snapshot
Factors associated with hepatic fibrosis and its deterioration among fatty liver elderly: a retrospective cohort study
inferred← citeshttps://doi.org/10.21276/apjhs.2020.7.1.16openalex-snapshot
Prevalence of Nonalcoholic Fatty liver Disease (NAFLD) and its association with Cardio-metabolic risk factors in Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.21276/ijcmr.2019.6.8.52openalex-snapshot
Prevalence and Profile of Non-Alcoholic Fatty Liver Disease among Adults Undergoing Master Health Checkup, A Hospital based Cross Sectional Study
inferred← citeshttps://doi.org/10.2147/dddt.s142339openalex-snapshot
Pharmacokinetic and safety evaluation of MB12066, an NQO1 substrate
inferred← citeshttps://doi.org/10.2147/hmer.s64819openalex-snapshot
Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
inferred← citeshttps://doi.org/10.2147/ott.s214870openalex-snapshot
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
inferred← citeshttps://doi.org/10.21608/aeji.2018.8734openalex-snapshot
Risk of Ischemic Heart Disease in Patients with Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.21608/bmfj.2020.116856openalex-snapshot
Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse
showing the first 200 of 269 · page through all 269
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.